
2026 PDA Virus Conference
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2026 PDA Virus Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
About this event
PDA Virus Conference 2026
Event type: Virology, infectious disease research, vaccine development, clinical diagnostics, laboratory science, pharmaceutical R&D, public health, and regulatory science
Best use case: Deep buyer research for companies selling lab technologies, diagnostics, reagents, biosafety products, data platforms, sample management tools, research services, vaccines, antiviral development solutions, clinical trial services, and public health systems.
Executive summary
The PDA Virus Conference 2026 is best understood as a high-value scientific and commercial meeting for professionals working in virology, infectious disease prevention, vaccine research, laboratory testing, analytical methods, and regulatory-quality environments. Unlike a broad consumer or general healthcare event, this type of conference usually attracts a concentrated audience of decision-makers and technical influencers who are involved in research, product development, laboratory operations, clinical evaluation, and compliance.
For attendee-list buying, the strongest value is not just in the overall number of registrants, but in the quality of the audience. Buyers, evaluators, and technical specifiers at this event are likely to include R&D leaders, virologists, lab directors, clinical scientists, regulatory affairs specialists, biotech executives, public health researchers, and procurement decision-makers from organizations involved in diagnostics, vaccines, biologics, and laboratory infrastructure.
Before finalizing the best buyer segments, please share your client website so I can review the product category and identify the most relevant buyer profiles, industries, company types, and job titles for your exact offer. That step is critical because the ideal buyer list changes significantly depending on whether your client sells diagnostics, lab equipment, software, consulting, recruitment, reagents, clinical services, or research tools.
1️⃣ Who attends: Buyers / attendees
This conference is expected to attract a highly specialized life sciences and public health audience. The attendees are usually a mix of technical experts, business buyers, and operational decision-makers. For attendee-list purposes, the most valuable people are not only the scientists, but also the leaders who influence purchase decisions, vendor selection, research partnerships, and program budgets.
Primary attendee groups:
- Virologists and infectious disease researchers
- Research scientists and principal investigators
- Laboratory directors and lab managers
- Clinical microbiology and molecular diagnostics specialists
- Vaccine development teams
- Biotech and pharmaceutical R&D professionals
- Regulatory affairs and quality assurance professionals
- Public health experts and epidemiologists
- Clinical trial and translational research teams
- Procurement, sourcing, and vendor evaluation teams
- University faculty and academic researchers
- Government and nonprofit health program leaders
Buyer mindset: Many attendees will attend to evaluate new technology, find partners, compare methods, understand disease trends, or source laboratory and research solutions. This makes the event highly suitable for B2B lead generation, especially for companies selling into scientific and healthcare decision-making environments.
2️⃣ Where the show is happening + attendee geographic origin
Location: If the venue is not yet confirmed publicly, use the official event page or organizer announcement to verify the host city, convention center, and country before building the attendee list strategy.
Geographic origin: Conferences like this often draw a mix of local, national, and international attendees depending on the organizer, scientific reputation, and speaker lineup. Because virology and virus-related research is globally relevant, the attendee base may include professionals from:
- Local host-region hospitals, universities, labs, and biotech firms
- National research institutions and pharmaceutical companies
- International delegates from public health, life sciences, and diagnostic organizations
Target geography recommendation:
- If the event is in North America, focus first on the host city, surrounding state, and national U.S. buyer base
- If the event is in Europe or Asia, include regional biotech hubs, major hospital networks, and diagnostics firms
- If the event has a strong scientific reputation, international researchers and global pharma attendees become especially important
3️⃣ Audience reach: Local / National / Global
Reach type: National to Global
Virus and virology conferences tend to have broader reach than a standard local healthcare event because the subject matter is tied to worldwide disease surveillance, vaccine development, infectious disease preparedness, and laboratory innovation. Even if the physical show is hosted in one city, the speaker network, research topics, sponsor base, and participant list often extend well beyond the host region.
If the organizer has strong academic or professional society backing, the event may have a truly global audience. If the event is more regional, it may still be national in reach with international relevance. For list-building purposes, it is safest to treat it as a high-quality national-plus event with global influence.
4️⃣ Sample buyer company names + websites
Below is a sample buyer-style account list you can use as a starting point. These are companies and organizations likely to buy, influence, sponsor, research, or support virus-related science, diagnostics, vaccines, lab systems, and public health solutions.
| Priority | Company | Website | Best Title to Target | Why This is a Good Buyer Fit |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | thermofisher.com | Director of Molecular Diagnostics / R&D Procurement Manager | Strong buyer for lab instruments, reagents, diagnostic workflows, and research platforms. |
| 2 | Abbott | abbott.com | Senior Director, Infectious Disease Diagnostics | Major diagnostics player with direct relevance to virus testing and clinical detection. |
| 3 | Roche | roche.com | Head of Diagnostics Partnerships / Clinical Affairs Lead | Excellent fit for molecular diagnostics, assays, and clinical research collaborations. |
| 4 | Pfizer | pfizer.com | Vaccine Program Manager / Virology R&D Director | Highly relevant for vaccine research, antiviral development, and scientific partnerships. |
| 5 | Moderna | moderna.com | Director, Clinical Development / Research Partnerships Manager | Strong fit for viral vaccine innovation, translational research, and clinical studies. |
| 6 | GSK | gsk.com | Medical Affairs Director / Infectious Disease Strategy Lead | Relevant for vaccines, infectious disease programs, and scientific engagement. |
| 7 | Bio-Rad Laboratories | bio-rad.com | Product Manager, Molecular Diagnostics | Good fit for PCR, assay systems, and lab workflow solutions. |
| 8 | QIAGEN | qiagen.com | Global Marketing Manager, Infectious Disease | Highly aligned with sample prep, molecular testing, and virus detection tools. |
| 9 | Danaher | danaher.com | Business Development Director, Diagnostics | Parent company to multiple diagnostic and life science brands with strong buying relevance. |
| 10 | BD | bd.com | Clinical Applications Manager / Lab Solutions Director | Strong buyer for specimen collection, diagnostics, and laboratory systems. |
| 11 | BioNTech | biontech.com | Head of Virology Research / Alliance Manager | Good for vaccine research, immunology, and advanced development partnerships. |
| 12 | Novavax | novavax.com | Program Director, Vaccine Development | Directly relevant to virus-related vaccine innovation and trial operations. |
| 13 | Charles River Laboratories | criver.com | Director, Preclinical Services / Study Director | Strong fit for research outsourcing, testing, and development support. |
| 14 | Labcorp | labcorp.com | Vice President, Diagnostics Operations | Major clinical diagnostics organization with high relevance to virus testing. |
| 15 | Quest Diagnostics | questdiagnostics.com | Senior Manager, Infectious Disease Testing | Large-scale diagnostic testing buyer with continuous demand for technology and services. |
| 16 | Merck | merck.com | Director, Vaccine and Infectious Disease Research | Excellent target for virology, vaccines, and translational science. |
| 17 | Helix | helix.com | Director of Genomics Partnerships | Relevant where viral genomics, sequencing, and surveillance are key themes. |
| 18 | Illumina | illumina.com | Director, Clinical Marketing / Scientific Affairs Lead | Strong fit for sequencing, pathogen analysis, and research technology adoption. |
| 19 | Cepheid | cepheid.com | Product Manager, Infectious Disease | Highly aligned with rapid molecular diagnostics and test platforms. |
| 20 | Emory University | emory.edu | Professor of Infectious Diseases / Lab Director | Academic and research influence is often central in virus conferences and collaborations. |
Top 5 buyer accounts to prioritize first: Thermo Fisher Scientific, Abbott, Roche, Pfizer, and Moderna. These names offer the strongest combination of budget, relevance, technical complexity, and potential for vendor engagement.
5️⃣ Job profiles, industries & event type
Best job titles to target:
- Director of Virology
- Head of Infectious Disease Research
- Laboratory Director
- Clinical Diagnostics Manager
- Scientific Affairs Director
- R&D Director
- Medical Science Liaison
- Product Manager, Diagnostics
- Regulatory Affairs Manager
- Quality Assurance Manager
- Translational Research Director
- Public Health Program Manager
- Procurement Manager, Life Sciences
- Business Development Director
- University Research Professor
Best industries to use from your industry list:
- Biotechnology
- Pharmaceuticals
- Research
- Medical Devices
- Hospital & Health Care
- Health, Wellness & Fitness
- Higher Education
- Education Management
- Government Administration
- Public Policy
- Information Services
- Information Technology & Services
- Management Consulting
- Environmental Services
- Veterinary
- Insurance
- Staffing & Recruiting
- Professional Training & Coaching
Event type categories: Scientific conference, healthcare research event, diagnostics expo, biotechnology networking, public health forum, regulatory science meeting, and clinical innovation conference.
6️⃣ Estimated attendance: expected total footfall
Estimated attendance range: 1,000 to 5,000+ depending on scale, location, and organizer reputation
Virus-focused scientific conferences are often smaller than mass-market trade shows, but they can be extremely valuable because of the quality of the audience. A well-positioned conference in this category may have a few hundred to a few thousand attendees, including researchers, sponsors, healthcare professionals, students, and exhibitor staff. If the event is part of a larger congress or includes a major expo component, attendance can increase substantially.
How to evaluate footfall value:
- Not just total attendance, but percentage of decision-makers
- How many exhibitors, sponsors, and poster presenters are involved
- Whether the conference includes a commercial exhibition floor
- Whether industry roundtables, product demos, or partnering sessions are included
7️⃣ Key focus areas & buyer engagement
Core focus areas likely to matter most:
- Virus detection and molecular diagnostics
- Vaccine research and development
- Infectious disease surveillance
- Sequencing and genomic analysis
- Clinical testing and assay validation
- Biosafety and laboratory workflow
- Outbreak preparedness and public health response
- Translational research and clinical trials
- Biomanufacturing and process development
- Data analysis, AI, and research informatics
Buyer engagement opportunities:
- Sponsored speaking slots on research innovation or diagnostics trends
- Exhibitor booths for lab instruments, reagents, and software
- Scientific roundtables and expert panels
- One-to-one meetings with lab and research leaders
- Product demos for testing platforms and workflow tools
- Lead capture through poster sessions, networking receptions, and breakouts
Best messaging angle: Position your list as a buyer intelligence opportunity, not simply an attendee database. The strongest value is in reaching professionals who influence scientific purchasing, research outsourcing, diagnostic adoption, and vendor selection.
8️⃣ Client-product fit note
To identify the best buyers for this conference, I need the client website so I can review the product or service offering first. The ideal contacts change based on what the client sells.
If the client sells diagnostics or lab equipment: target lab directors, diagnostics managers, procurement leaders, and product development heads at biotech, pharma, and clinical labs.
If the client sells software or data platforms: target scientific informatics leaders, bioinformatics teams, clinical trial teams, and research operations professionals.
If the client sells consulting or services: target R&D directors, regulatory affairs, business development leaders, and academic research institutions.
If the client sells recruitment or staffing solutions: target biotech, pharma, diagnostics, and hospital talent acquisition leaders, as well as temporary scientific staffing managers.
If the client sells reagents or consumables: target purchasing managers, lab operations leaders, and principal investigators with active research budgets.
9️⃣ Suggested industry targeting strategy
For database building and outreach, the strongest industry targeting logic would be:
- Primary: Biotechnology, Pharmaceuticals, Research, Medical Devices, Hospital & Health Care
- Secondary: Higher Education, Education Management, Government Administration, Public Policy
- Support categories: Information Services, Information Technology & Services, Professional Training & Coaching, Staffing & Recruiting
This layered approach helps you capture the buyers who directly purchase, the influencers who evaluate, and the institutions that shape future research and procurement.
Final recommendation
The PDA Virus Conference 2026 is likely to be a strong event for buyer-list research if your client sells into life sciences, diagnostics, vaccines, laboratory operations, research services, or public health. It is especially valuable when the targeting strategy focuses on senior scientific titles, lab decision-makers, procurement influencers, and commercial teams inside biotech and pharma organizations.
Buyer fit quality rating: 8.5/10
Why the score is high: The audience is specialized, commercially relevant, and more likely than a general event audience to include decision-makers with real purchasing power. The only caution is that the attendee base may also include a strong academic and research component, so the best results come from filtering carefully by job title, seniority, and industry.
Next step: Share your client website, and I will tailor the exact best buyer profiles, company names, industries, and outreach priorities based on the product and target market.
Data sheet
| Event Overview | |
|---|---|
| Event Name | 2026 PDA Virus Conference |
| Event Date | 22–23 June 2026 |
| Event Status | Upcoming |
| Venue | Austria Trend Parkhotel Schönbrunn |
| City | Vienna |
| State / Region | Vienna |
| Country | Austria |
| Organizer | PDA (Parenteral Drug Association) |
| Official Event Website | PDA conference listing and event detail pages |
| Event Type | Scientific conference / technical industry meeting |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Wellness, Health & Fitness; Business Services |
| Audience Reach | Global scientific and pharmaceutical audience, with strong Europe-based participation expected |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. |
| Attendance Data Reliability | Moderate for event format and audience type; low for current-year headcount because no public count was confirmed |
| Main Purpose of Event | To share advances in virology, infectious disease research, vaccine development, diagnostics, and regulated laboratory science, while connecting technical experts, solution providers, and industry stakeholders |
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| R&D / Virology Leaders | Pharma, biotech, vaccine developers, infectious disease labs | Method selection, technology evaluation, research investment | High-value for assays, reagents, instruments, and research services |
| Laboratory Directors / Lab Managers | Reference labs, hospital labs, CROs, public health labs | Operational purchasing, validation, workflow adoption | Strong fit for lab consumables, equipment, automation, and software |
| Clinical Scientists / Translational Researchers | Hospitals, academic medical centers, biotech firms | Protocol design, study execution, evidence generation | Relevant for diagnostics, sample handling, data platforms, and CRO services |
| Regulatory Affairs / Quality Leaders | Pharma, biotech, diagnostics, device manufacturers | Compliance, submission strategy, supplier qualification | Important for regulated software, validation services, and GMP-support products |
| Procurement / Strategic Sourcing Teams | Pharma manufacturers, hospitals, research institutions, distributors | Vendor selection, contract negotiation, sourcing strategy | Highly relevant for recurring consumables, instruments, and service agreements |
| Public Health / Government Scientists | National institutes, ministries, disease control agencies | Program selection, testing policy, public-sector procurement influence | Relevant for surveillance tools, diagnostics, and outbreak-response solutions |
| Biotech / Pharma Executives | Emerging biotech, mid-size pharma, vaccine companies | Budget approval, partnership strategy, technology adoption | Strong for enterprise solution sales and strategic partnerships |
| CRO / CDMO Leaders | Contract research and manufacturing organizations | Service acquisition, platform choices, client-facing capability expansion | Relevant for testing services, outsourced analytics, and compliance tools |
| Technology / Informatics Leaders | Labs, pharma IT, clinical data organizations | Platform evaluation, integration, data governance | Relevant for LIMS, data systems, analytics, AI, and secure collaboration tools |
| Association / Standards Leaders | Industry associations, standards bodies, scientific societies | Policy influence, educational programming, networking and standards alignment | Useful for thought leadership and institutional partnerships |
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host City: Vienna | Local universities, hospitals, biotech offices, public-sector researchers | Medium | Vienna is a strong life-sciences and conference hub with access to technical decision-makers |
| Host Region: Austria | National pharma, clinical, research, and public health stakeholders | Medium to High | Likely draw from Vienna, Lower Austria, Styria, and key research centers across the country |
| Nearby Business Hubs | Central Europe life-sciences and healthcare organizations | High | Strong reach into Germany, Switzerland, Czech Republic, Slovakia, Hungary, and nearby EU markets |
| National Reach | Austria-wide scientific and commercial attendance | High | Likely includes researchers, suppliers, and clinical stakeholders from across Austria |
| International Reach | European and global virology / pharma community | High | PDA events typically attract cross-border technical and regulatory participants |
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | Virology, vaccine development, and regulated laboratory science are international disciplines; PDA conferences typically have broad cross-border relevance |
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| BioNTech SE | Biopharma / vaccine developer | Strong fit for virology, vaccine R&D, clinical development, and assay technologies | biontech.com | VP R&D, Director Virology, Head of Clinical Operations, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| CureVac N.V. | Biotech / RNA platform company | Relevant for vaccine research, analytical testing, and regulated development workflows | curevac.com | Chief Scientific Officer, Director of Translational Research, Quality Director | Strong Market Fit, Attendance Not Confirmed |
| Valneva SE | Vaccine developer | Directly aligned with virus, immunization, and vaccine-platform discussions | valneva.com | VP Clinical Development, Head of Regulatory Affairs, Director of Procurement | Strong Market Fit, Attendance Not Confirmed |
| Takeda Pharmaceutical Company Limited | Global pharma | Large R&D and clinical operations organization with viral disease and vaccine interest areas | takeda.com | Global Category Manager, Head of Virology, Clinical Science Lead | Strong Market Fit, Attendance Not Confirmed |
| Roche | Diagnostics / pharma | High relevance for diagnostics, lab workflow tools, and clinical testing applications | roche.com | Director Diagnostics, Lab Operations Lead, Strategic Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Abbott | Diagnostics / medical devices | Relevant for virology testing, clinical diagnostics, and lab instrumentation | abbott.com | Product Manager Diagnostics, Lab Director, Procurement Lead | Strong Market Fit, Attendance Not Confirmed |
| GSK | Global pharma / vaccines | Relevant for vaccine research, clinical trials, antiviral and immunology programs | gsk.com | Director of Clinical Operations, Head of Procurement, R&D Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Thermo Fisher Scientific | Life sciences tools / lab technology | Strong fit for instruments, reagents, sample prep, and workflow solutions | thermofisher.com | Bioprocess Manager, Laboratory Director, Purchasing Director | Strong Market Fit, Attendance Not Confirmed |
| Qiagen | Molecular diagnostics / life sciences | Aligned with sample prep, molecular assays, and diagnostic platforms | qiagen.com | Head of R&D, Category Manager, Lab Product Manager | Strong Market Fit, Attendance Not Confirmed |
| Charles River Laboratories | CRO / preclinical services | Relevant for infectious disease research, testing services, and outsourced studies | criver.com | Business Development Director, Study Director, Sourcing Manager | Strong Market Fit, Attendance Not Confirmed |
| Eurofins Scientific | Testing / laboratory services | Relevant for lab testing, virology assays, and quality-controlled services | eurofins.com | Lab Services Director, Operations Manager, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Austrian Agency for Health and Food Safety (AGES) | Government / public health | Highly relevant for surveillance, diagnostics, and public health response | ages.at | Public Health Scientist, Lab Head, Procurement Officer | Strong Market Fit, Attendance Not Confirmed |
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Scientific Officer / Head of R&D | Research & Development | C-Level / VP | Owns research direction, platform adoption, and major technology investments |
| 2 | Director of Virology / Infectious Disease Research | Scientific Affairs | Director | Direct evaluator of assays, reagents, models, and research services |
| 3 | Laboratory Director / Lab Manager | Laboratory Operations | Director / Manager | Controls operational buying and workflow implementation |
| 4 | Clinical Development Director / Clinical Scientist | Clinical Development | Director / Senior Manager | Evaluates clinical programs, trial support services, and data workflows |
| 5 | Regulatory Affairs Director / Quality Director | Regulatory / Quality | Director | Influences qualification, validation, and compliant product selection |
| 6 | Procurement Manager / Strategic Sourcing Manager | Procurement / Supply Chain | Manager / Director | Key buyer for recurring consumables, services, and instrument contracts |
| 7 | Product Manager / Market Access Manager | Commercial / Product | Manager / Senior Manager | Translates customer requirements into product and go-to-market priorities |
| 8 | IT Director / Data Systems Lead | Information Technology / Informatics | Director / Head of | Relevant for LIMS, analytics, secure data exchange, and digital lab systems |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Pharmaceuticals | Core audience for vaccines, antivirals, and regulated development | R&D, clinical, procurement, and quality stakeholders |
| 2 | Biotechnology | Strong fit for infectious disease and platform innovation | Scientific leads, business development, and operations leaders |
| 3 | Medical Devices | Relevant for diagnostics and lab workflow solutions | Product, regulatory, and sourcing teams |
| 4 | Hospital & Health Care | Major buyer group for diagnostics and testing workflows | Lab directors, clinical operations, procurement |
| 5 | Research | Fits academic, translational, and applied virology research | Principal investigators, lab managers, research administrators |
| 6 | Government Administration | Public health and surveillance buyers are relevant to viral preparedness | Procurement, lab, and policy stakeholders |
| 7 | Health, Wellness & Fitness | Broad healthcare ecosystem relevance | Healthcare operations and strategic buyers |
| 8 | Information Technology & Services | Important for lab informatics, data integration, and workflow digitization | IT, analytics, security, and platform teams |
| 9 | Biotechnology Research | Not an Apollo industry label; use Biotechnology and Research together for targeting | Research-heavy buyer segmentation |
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed non-disclosure | Organizer did not publicly publish a headcount in the information reviewed | Use audience quality rather than raw count for list-buying value |
| Exhibitor count | Not publicly confirmed | Not confirmed | No verified public exhibitor directory reviewed | Scientific conferences of this type may have limited sponsor presence |
| Buyer count | Not publicly confirmed | Not confirmed | Attendance breakdown not publicly released | Likely mix of scientists, lab leaders, and commercial decision-makers |
| Speaker count | Not publicly confirmed | Not confirmed | No verified current-year speaker list reviewed | Speaker quality is likely more useful than speaker quantity for targeting |
| Historical attendance | Not publicly confirmed | Unavailable | No reliable prior-year public total verified in the information reviewed | Attendance figure not publicly confirmed by the organizer. |
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Virology R&D | New methods, platforms, and research support | Technical demos, scientific discussions, application notes | Assays, reagents, instruments, research services |
| Diagnostics | Sensitivity, turnaround time, workflow efficiency | Application-based sales conversations and validation support | Molecular diagnostics, sample prep, automation, QA tools |
| Vaccine Development | Preclinical and clinical support, scale-up, quality | Partnership and supplier qualification discussions | Bioprocessing, analytics, clinical trial services, compliance support |
| Biosafety / Containment | Safe handling of infectious materials and regulated operations | Operational pain-point discovery and risk reduction messaging | PPE, containment systems, decontamination, monitoring products |
| Sample Management | Chain of custody, storage, traceability, logistics | Workflow optimization and compliance-focused outreach | LIMS, inventory systems, cold chain, barcoding solutions |
| Regulatory Science | Documentation, validation, audit readiness | Compliance and quality-focused account outreach | Validation services, QMS software, GxP-support tools |
| Public Health Preparedness | Rapid response, surveillance, testing capacity | Government and institutional buyer messaging | Surveillance tools, outbreak analytics, testing platforms |
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Audience likely includes technical decision-makers and budget-influencing stakeholders in pharma, diagnostics, and research |
| Decision-maker availability | High | Scientific conferences often bring together senior researchers, lab leaders, and commercial leads |
| Data collection potential | Medium | Best when using agenda, speaker, sponsor, and association data; attendee list may not be public |
| Apollo targeting potential | Very High | Clear fit for pharma, biotech, diagnostics, government, and research-based company filtering |
| Geographic targeting potential | High | Vienna and Central Europe create a strong regional targeting angle with global scientific reach |
| Best outreach approach | Technical, educational, and solution-led | Lead with problem/solution fit, application value, and compliance relevance rather than generic event promotion |
| Overall lead quality | High | Strong event for specialist B2B list building in life sciences and regulated healthcare markets |
| Best use case | Targeted prospecting for lab tech, diagnostics, reagents, biosafety, and research service providers | Best suited to technical sales, account-based marketing, and attendee profiling |
| Limitations / risks | Moderate | Current-year attendee and exhibitor data may not be public, so prospecting should not overstate confirmed participation |
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Pharmaceuticals, Biotechnology, Medical Devices, Hospital & Health Care, Research, Government Administration, Information Technology & Services, Environmental Services | Focus on the most likely buyer pools for virology and diagnostics solutions |
| Departments | R&D, Clinical, Laboratory, Procurement, Quality, Regulatory Affairs, Operations, IT | Reach both technical evaluators and commercial buyers |
| Seniority | Manager, Director, VP, C-level, Head of | Prioritize decision-makers and budget owners |
| Job titles | Chief Scientific Officer, VP R&D, Director Virology, Lab Director, Procurement Manager, Regulatory Affairs Director, Clinical Development Director, Product Manager, IT Director | Match the buying committee around lab and clinical solutions |
| Geography | Austria, Germany, Switzerland, Italy, Czech Republic, Slovakia, Hungary, Slovenia, broader EU, United Kingdom | Capture Vienna-based and regional attendees likely to travel for the conference |
| Employee size | 51–200, 201–500, 501–1,000, 1,001–5,000, 5,001+ | Covers mid-market biotech, CROs, and enterprise pharma buyers |
| Keywords | virology, vaccine, viral, infectious disease, diagnostics, assay, biosafety, LIMS, laboratory, sample management, GxP, clinical research | Improve relevance for event-specific prospecting |
| Company type | Public companies, private companies, research institutions, hospitals, government agencies, CRO/CDMO | Prioritize organizations with structured purchasing and technical buying teams |
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| Parenteral Drug Association (PDA) | Official organizer website | Organizer identity, event-series context, and technical conference positioning | High |
| Austria Trend Parkhotel Schönbrunn | Venue website | Venue name and Vienna location | High |
| PDA Global Event Calendar | Official event listing page | Event timing and conference-series classification where publicly listed | High |
| PDA Events / Conference Pages | Official event directory | Typical audience type, technical focus, and conference structure | High |
| PDA conference pages and associated materials | Official agenda / brochure ecosystem | Scientific and commercial subject-matter relevance for virology and regulated life-science buyers | Moderate to High |
| Client-provided event description | User-supplied briefing | Use case, topical relevance, and commercial positioning | Medium |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to 2026 PDA Virus Conference — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.